Total planned funding: $2,176,647,281
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $390,897,733 |
Tanzania | $374,799,086 |
Zambia | $233,406,145 |
Uganda | $169,336,563 |
Mozambique | $154,982,500 |
Kenya | $151,994,372 |
Ethiopia | $112,481,690 |
South Africa | $89,072,267 |
Côte d'Ivoire | $78,655,155 |
Zimbabwe | $78,065,893 |
Rwanda | $69,732,330 |
Haiti | $45,166,231 |
Eswatini | $35,647,189 |
Democratic Republic of the Congo | $32,589,619 |
Vietnam | $26,185,301 |
Namibia | $20,708,087 |
Botswana | $20,419,957 |
Malawi | $18,361,812 |
Ukraine | $15,320,282 |
Lesotho | $13,364,664 |
Burundi | $5,073,768 |
Central America Region | $4,731,616 |
Ghana | $4,682,071 |
Guyana | $4,360,357 |
Cambodia | $3,950,000 |
Cameroon | $3,889,915 |
South Sudan | $3,309,375 |
Angola | $3,100,000 |
Caribbean Region | $2,632,881 |
Indonesia | $2,350,000 |
Russia | $1,850,000 |
India | $1,689,272 |
Burma | $1,575,000 |
Asia Regional Program | $1,550,000 |
China | $716,150 |
Central Asia Region | $0 |
Dominican Republic | $0 |
Organizational Types
Private Contractor | $2,176,647,281 |
Program Areas
Treatment | $1,312,821,880 |
Care | $285,891,252 |
Governance and Systems | $278,643,006 |
Prevention | $180,923,980 |
Testing | $114,911,046 |
Budget Codes
HTXD: Treatment: ARV Drugs | $936,822,050 |
HTXS: Treatment: Adult Treatment | $346,706,213 |
OHSS: Health Systems Strengthening | $153,323,825 |
HBHC: Care: Adult Care and Support | $144,748,071 |
HVCT: Testing: HIV Testing and Counseling | $114,911,046 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $75,880,461 |
HKID: Care: Orphans and Vulnerable Children | $74,758,577 |
HLAB: Laboratory Infrastructure | $70,824,325 |
HVSI: Strategic Information | $54,494,856 |
HVTB: Care: TB/HIV | $46,207,743 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $37,422,462 |
HVOP: Sexual Prevention: Other Sexual Prevention | $31,198,590 |
PDTX: Treatment: Pediatric Treatment | $29,293,617 |
PDCS: Care: Pediatric Care and Support | $20,176,861 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $15,050,713 |
HMIN: Biomedical Prevention: Injection Safety | $14,050,725 |
HMBL: Biomedical Prevention: Blood Safety | $4,867,440 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,453,589 |
Top Partner Programs
Chemonics International:
$683,409,738
View countries
John Snow, Inc:
$64,063,704
View countries